Baker-Polito Administration Announces $19.5 Million Job Creation Incentives for 28 Massachusetts Life Sciences Companies
Baker-Polito Administration Announces $19.5 Million Job Creation Incentives for 28 Massachusetts Life Sciences Companies
AXONIS Therapeutics Announces $5 Million in Funding; Provides Update on Progress Advancing Novel Therapeutics for Neurological Disorders
AXONIS Therapeutics, Inc., an emerging biotechnology company advancing breakthrough research to develop therapies for neurological disorders, today announced it has secured an additional $5 million in funding. This financing round,...
Read MoreKephera Diagnostics launches CLIA test for quantitative antibody response to COVID-19 vaccination
Kephera Diagnostics announced today the launch of a quantitative test to measure the level of antibodies elicited by vaccination against COVID-19, as well as by COVID-19 infection. The test will...
Read MoreBaker-Polito Administration Announces $18 Million in Life Sciences Capital Funding to Support Research Infrastructure, Data Science, and Drug Delivery Projects
Fourteen projects receiving funding to support R&D, innovation in addressing challenges in therapeutic delivery and unlocking potential of data science to answer pressing life sciences questions Today, the Baker-Polito Administration...
Read MoreBaker-Polito Administration Announces $3.4 Million to Support STEM Equipment and Teacher Professional Development
Twenty-seven awards will support new and expanded curricula at 93-plus schools, serving more than 38,200 students, and more than 730 teachers receiving professional development Today, the Baker-Polito Administration and the...
Read MoreTakeda Unveils Newly Renovated Building at 500 Kendall Street in Cambridge, Massachusetts, Solidifying Presence in Fast-Growing Biopharmaceutical Community
Takeda recently completed renovation of our 500 Kendall Street building in Cambridge, MA. The building will now serve as a centerpiece in Takeda’s interconnected network of buildings across our three...
Read MoreModerna Reaffirms Commitment to Job Creation in Massachusetts
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reaffirmed its commitment to job creation in Massachusetts. Over the last year, Moderna nearly doubled the size...
Read MorePanTher Therapeutics Closes Oversubscribed $5.4M Series A Round, Expands Board of Directors, As Company Prepares to Initiate First Clinical Trial of Novel Localized Treatment of Pancreatic Cancer
PanTher Therapeutics, a privately held oncology company revolutionizing the treatment of solid tumors through direct, localized, and sustained delivery of proven and novel therapeutic agents, announces today that it has...
Read MoreBaker-Polito Administration Announces $19.5 Million Job Creation Incentives for 28 Massachusetts Life Sciences Companies
Incentives expected to create 1,259 life sciences jobs throughout Massachusetts, with 68 percent of job growth taking place outside of Greater Boston Today, the Baker-Polito Administration and Massachusetts Life Sciences...
Read More